EASL–EASD–EASO clinical practice guidelines for the management of non-alcoholic fatty liver disease in severely obese people: do they lead to over-referral?

EASL–EASD–EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease

Journal of Hepatology · 2016 · 4.8K citations

Obesity, Metabolic Syndrome, Metabolic Associated Steatohepatitis +10

The diagnosis and management of non-alcoholic fatty liver disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association

Naga Chalasani, Zobair M. Younossi, Joel E. Lavine et al. · Hepatology · 2012 · 3.8K citations

The NAFLD fibrosis score

Paul Angulo, Jason M. Hui, Giulio Marchesini et al. · Hepatology · 2007 · 3.1K citations · Full text

Liver Fibrosis, but No Other Histologic Features, Is Associated With Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease

Paul Angulo, David E. Kleiner, Sanne Dam‐Larsen et al. · Gastroenterology · 2015 · 2.9K citations · Full text

Metabolic Associated Steatohepatitis, Fibrosis, Hepatology +14

Fibrosis stage is the strongest predictor for disease‐specific mortality in NAFLD after up to 33 years of follow‐up

Mattias Ekstedt, Hannes Hagström, Patrik Nasr et al. · Hepatology · 2014 · 2.2K citations · Full text